In both in vivo and in vitro model of cerebral ischemia, combining HDAC inhibitors with very low doses of resveratrol exerted synergistic neuroprotective effects, significantly prolonging neuroprotection (Lanzillotta et al., 2013). Here, HDAC9 is linked to Cerebral ischemia.